BioRestorative Therapies Inc (BRTX)

[trader59]

If the company’s product had any sort of potential value like that, someone in the industry who funds these trials and that they’ve pitched to would have invested in them in the 3 years since the FDA approved their trial. Nobody did, so they upped their O/S, converted enough debt into shares to bloat the O/S up to over 1.6B from a starting point of 43M, tried to do a RS and failed, and then went into bankruptcy over $15M of debt.

There isn’t a way for a company with multi-billion dollar value to land in bankruptcy over $15M of debt. This one did, and the creditors are mainly toxic lenders already. When and if they exit this bankruptcy, they’ll still be looking for the trial funding.